Dr Holger Auner is Clinical Reader in Molecular Haemato-oncology at Imperial College London. He received his MD from Karl-Franzens University Graz, Austria, where he also trained in Internal Medicine\/Haematology-Oncology and studied genetic instability in myeloid leukaemias in the laboratory of Professor Heinz Sill. He was awarded a\u00a0Kay Kendall Leukaemia Fund Junior Research Fellowship\u00a0 to join the group of Professor Niall Dillon at the MRC Clinical Sciences Centre in London and obtained his PhD for work on plasma cell biology from Imperial College London. He was the recipient of a\u00a0Cancer Research UK (CRUK) Clinician Scientist Fellowship\u00a0in 2012, enabling him to establishe a research group in the Centre for Haematology at Imperial College London. Currently, he holds a\u00a0CRUK Advanced Clinician Scientist\u00a0Fellowship, is Head of Translational Research\u00a0at\u00a0Imperial’s Hugh and Josseline Langmuir Centre for Myeloma Research and is an Honorary Consultant in Haematology (Imperial College Healthcare NHS Trust).\u00a0Dr Auner\u2019s primary research interest is to better understand the molecular\u00a0mechanisms that coordinate\u00a0protein degradation pathways with cellular metabolism in multiple myeloma and other cancers. His lab also investigates how\u00a0proteomic and metabolic homeostasis depend\u00a0on tissue physical properties and\u00a0vice versa,\u00a0using time-resolved omics approaches in a range of cross-disciplinary collaborations with academic and pharmaceutical industry partners. Dr Auner\u00a0is board member of the UK Myeloma Research Alliance (UKMRA), member of the European Myeloma Network (EMN), and principal\/chief investigator of national and international phase 1 to 3 trials.<\/p>\n","protected":false},"author":{"id":1,"first_name":"Francisco","nickname":"Superadmin","email":"jose.santos@cor2ed.com"},"featured_media":388,"menu_order":299,"template":"","groups":[25],"class_list":["post-389","experts","type-experts","status-publish","has-post-thumbnail","hentry","groups-myeloma-connect"],"expert_info_prefix":"Dr","expert_info_first-name":"Holger W","expert_info_last-name":"Auner","expert_info_institution":"Imperial College London","expert_info_country":"GB","expert_info_specialization":"Haemato-oncologist","expert_info_map-code":"","expert_info_disclosures":"
Amgen, Apollo Therapeutics, Janssen, Karyopharm and Takeda.\u00a0<\/p>","expert_info_linkedin":"","expert_info_twitter":"","expert_info_instagram":"","expert_info_facebook":"","_links":{"self":[{"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/experts\/389","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/experts"}],"about":[{"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/types\/experts"}],"version-history":[{"count":2,"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/experts\/389\/revisions"}],"predecessor-version":[{"id":88434,"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/experts\/389\/revisions\/88434"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/media\/388"}],"wp:attachment":[{"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/media?parent=389"}],"wp:term":[{"taxonomy":"groups","embeddable":true,"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/groups?post=389"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}